Annual Total Expenses
$592.54 M
-$81.06 M-12.03%
December 31, 2023
Summary
- As of February 7, 2025, CRSP annual total expenses is $592.54 million, with the most recent change of -$81.06 million (-12.03%) on December 31, 2023.
- During the last 3 years, CRSP annual total expenses has risen by +$237.56 million (+66.92%).
- CRSP annual total expenses is now -12.03% below its all-time high of $673.60 million, reached on December 31, 2022.
Performance
CRSP Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$110.13 M
-$41.13 M-27.19%
September 30, 2024
Summary
- As of February 7, 2025, CRSP quarterly total expenses is $110.13 million, with the most recent change of -$41.13 million (-27.19%) on September 30, 2024.
- Over the past year, CRSP quarterly total expenses has dropped by -$20.29 million (-15.56%).
- CRSP quarterly total expenses is now -39.96% below its all-time high of $183.42 million, reached on June 30, 2022.
Performance
CRSP Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CRSP Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.0% | -15.6% |
| 3 y3 years | +66.9% | -14.8% |
| 5 y5 years | +265.6% | +51.4% |
CRSP Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.0% | +9.8% | -40.0% | at low |
| 5 y | 5-year | -12.0% | +144.0% | -40.0% | +66.8% |
| alltime | all time | -12.0% | +8841.3% | -40.0% | +1675.7% |
CRISPR Therapeutics AG Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $110.13 M(-27.2%) |
| Jun 2024 | - | $151.26 M(+7.6%) |
| Mar 2024 | - | $140.59 M(+7.8%) |
| Dec 2023 | $592.54 M(-12.0%) | $130.42 M(-1.5%) |
| Sep 2023 | - | $132.41 M(-19.9%) |
| Jun 2023 | - | $165.22 M(+0.4%) |
| Mar 2023 | - | $164.49 M(+25.0%) |
| Dec 2022 | $673.60 M(+24.8%) | $131.55 M(-27.9%) |
| Sep 2022 | - | $182.48 M(-0.5%) |
| Jun 2022 | - | $183.42 M(+4.1%) |
| Mar 2022 | - | $176.15 M(+11.5%) |
| Dec 2021 | $539.55 M(+52.0%) | $158.05 M(+22.3%) |
| Sep 2021 | - | $129.18 M(-6.1%) |
| Jun 2021 | - | $137.58 M(+19.9%) |
| Mar 2021 | - | $114.75 M(+6.3%) |
| Dec 2020 | $354.98 M(+46.2%) | $107.95 M(+16.6%) |
| Sep 2020 | - | $92.55 M(+14.6%) |
| Jun 2020 | - | $80.73 M(+9.5%) |
| Mar 2020 | - | $73.74 M(+11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $242.85 M(+49.8%) | $66.03 M(-9.3%) |
| Sep 2019 | - | $72.77 M(+31.6%) |
| Jun 2019 | - | $55.30 M(+13.4%) |
| Mar 2019 | - | $48.75 M(+7.5%) |
| Dec 2018 | $162.07 M(+53.4%) | $45.34 M(-9.3%) |
| Sep 2018 | - | $49.99 M(+30.3%) |
| Jun 2018 | - | $38.37 M(+35.3%) |
| Mar 2018 | - | $28.36 M(-9.6%) |
| Dec 2017 | $105.64 M(+44.1%) | $31.35 M(+20.8%) |
| Sep 2017 | - | $25.96 M(+4.3%) |
| Jun 2017 | - | $24.89 M(+6.1%) |
| Mar 2017 | - | $23.45 M(-15.2%) |
| Dec 2016 | $73.29 M(+182.2%) | $27.65 M(+71.1%) |
| Sep 2016 | - | $16.16 M(-6.9%) |
| Jun 2016 | - | $17.35 M(+43.1%) |
| Mar 2016 | - | $12.13 M(-2.3%) |
| Dec 2015 | $25.98 M(+292.0%) | $12.41 M(+100.1%) |
| Sep 2015 | - | $6.20 M |
| Dec 2014 | $6.63 M | - |
FAQ
- What is CRISPR Therapeutics AG annual total expenses?
- What is the all time high annual total expenses for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual total expenses year-on-year change?
- What is CRISPR Therapeutics AG quarterly total expenses?
- What is the all time high quarterly total expenses for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly total expenses year-on-year change?
What is CRISPR Therapeutics AG annual total expenses?
The current annual total expenses of CRSP is $592.54 M
What is the all time high annual total expenses for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total expenses is $673.60 M
What is CRISPR Therapeutics AG annual total expenses year-on-year change?
Over the past year, CRSP annual total expenses has changed by -$81.06 M (-12.03%)
What is CRISPR Therapeutics AG quarterly total expenses?
The current quarterly total expenses of CRSP is $110.13 M
What is the all time high quarterly total expenses for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total expenses is $183.42 M
What is CRISPR Therapeutics AG quarterly total expenses year-on-year change?
Over the past year, CRSP quarterly total expenses has changed by -$20.29 M (-15.56%)